N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Brand names,
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Analogs
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Brand Names Mixture
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Chemical_Formula
C21H27N3O2
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
RX_link
http://www.rxlist.com/cgi/generic3/sansert.htm
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
fda sheet
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
msds (material safety sheet)
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Synthesis Reference
No information avaliable
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Molecular Weight
353.458 g/mol
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Melting Point
195 oC
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
H2O Solubility
No information avaliable
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
State
Solid
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
LogP
1.55
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Dosage Forms
Tablet
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Indication
For the treatment of vascular headache
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Pharmacology
Methysergide has been shown, in vitro and in vivo, to inhibit or block the effects of serotonin, a substance which may be involved in the mechanism of vascular headaches. Serotonin has been variously described as a central neurohumoral agent or chemical mediator, as a "headache substance" acting directly or indirectly to lower pain threshold, as an intrinsic "motor hormone" of the gastrointestinal tract, and as a "hormone" involved in connective tissue reparative processes.
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Absorption
Rapid
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
side effects and Toxicity
No information avaliable
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Patient Information
No information avaliable
N-(alpha-(Hydroxymethyl)propyl)-1-methyl-dextro-lysergamide
Organisms Affected
Humans and other mammals